Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure?☆☆☆
Abstract
Introduction: Worsening renal function during hospitalization for heart failure, defined as elevation in creatinine during admission, predicts adverse outcomes. Prior studies define worsening renal function using various creatinine elevations, but the relative value of definitions is unknown. Methods and Results: In a prospective cohort of 412 patients hospitalized for heart failure, we compared a spectrum of worsening renal function definitions (absolute creatinine elevations ≥0.1 to ≥0.5 mg/dL and 25% relative elevation from baseline) and associations with 6-month mortality, readmission, and functional decline. Creatinine elevation ≥0.1 mg/dL occurred in 75% of patients, and elevation ≥0.5 mg/dL occurred in 24% of patients. Risk of death rose with higher creatinine elevations (adjusted hazard ratio [HR] = 0.89, 1.19, 1.67, 1.91, and 2.90 for elevations ≥0.1 to ≥0.5 mg/dL). Maximum sensitivity of any definition for predicting mortality was 75% and maximum specificity was 79%. High creatinine elevation was a more important predictor of death than was a single measure of baseline creatinine. Conclusions: Larger creatinine elevations predict highest risk of death, yet even minor changes in renal function are associated with adverse outcomes. The choice of a “best definition” for worsening renal function has implications for the number of patients identified with this risk factor and the magnitude of risk for mortality.
Keywords: Sensitivity, mortality
To access this article, please choose from the options below
☆ Reprint requests to: Dr. Krumholz, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025.
☆☆ Dr. Watnick was a Robert Wood Johnson Clinical Scholar at Yale University during the time the work was conducted. She is currently affiliated with the Section of Nephrology, Oregon Health Sciences University and Portland VA Hospital.
PII: S1071-9164(02)25403-2
doi:10.1054/jcaf.2003.3
© 2003 Published by Elsevier Inc.
